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Abstract 
Human mesenchymal stem cells (hMSC) are a promising cell source for the 
manufacturing of cell therapeutic or tissue engineered implants. In part A of this 
publication a fixed-bed bioreactor system based on non-porous borosilicate glass 
spheres and procedures for the automated expansion of hMSC with high yield and 
vitality has been introduced. Part B of this study deals with the modeling of the 
process in order to transfer the bioreactors system from the laboratory to the 
production scale. Relevant model parameters have been obtained by fitting them to 
the experimental data of hMSC-TERT cultivations in scales up to 300 cm3. Scale-up 
calculations were carried out exemplarily for a target cell number of twenty billion 
cells. 
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Introduction 
Human mesenchymal stem cells (hMSC) or allogenic stem-cell lines are a promising 
cell source for the manufacturing of cell therapeutic implants such as 
microencapsulated hMSC-TERT for the treatment of diabetes mellitus or stroke [1, 2]. 
The expansion of the initial cell number to a relevant scale, especially for producing 
of at all times available implants in stock, demands an automatable and scalable 
bioreactor system which offers a gentle cultivation and harvesting of the cells. For 
that purpose a fixed bed bioreactor system based on non-porous borosilicate glass 
spheres with a diameter of 2 mm as well as inoculation, cultivation, and harvesting 
procedures, which fulfills the requirements stated above were introduced in part A of 
this publication [3] . It could be shown in previous studies that the chosen carriers are 
most suitable in respect to the nutrient supply and harvesting behavior [4]. 
Cultivations were performed in laboratory scales of up to 300 cm3 (Table 1) in order 
to develop the automatable expansion process. The model cell line hMSC-TERT was 
used throughout the experiments [5]. The developed inoculation procedure consists 
of the filling of the fixed bed with cell suspension and repeated perfusion steps (7 min 
with and 30 min without perfusion). Applying this procedure four times resulted in a 
yield of adhered cells of about 50%. A vitality of 97% and a yield of harvested cells of 
82% could be reached by perfusion of the fixed bed with AccutaseTM-solution in order 
to detach the cells from the carrier followed by flushing them out with the medium 
flow. The mean growth and consumption rates, calculated in a simplified manner 
(Table 2), are comparable to those published for stem cells and other animal cell 
types. Additional cultivations in 6-well cell culture plates were performed in order to 
determine the Monod kinetics of the growth and glucose consumption under static 
conditions (Table 5).   
The cultivations, introduced in part A of this publication, were used in this part to 
obtain the constants of the growth and consumption kinetics of the below-mentioned 
model by fitting them to the experimental data (Table 1)[3]. These parameters 
allowed in combination with the mathematical model scale-up calculations. In order to 
establish a practical relationship, the system was exemplarily scaled for the 
cultivation of 20 billion cells, which are sufficient for the production of about 200 
single doses of CellBeads® (CellMed AG, Alzenau, Germany). CellBeads® are 
therapeutic implants, which are currently in a clinical phase II study for the treatment 
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of stroke and consist of about 2000 to 2500 alginate encapsulated and genetically 
modified hMSC-TERT [1, 4, 6].  
 
Model equations 
The following assumptions and simplifications for modeling of the fixed bed process 
were made: 
• homogenous but time dependent concentration profile in the conditioning 
vessel 
• concentration profile in the fixed bed varies in time and axial direction  
• radial gradients are negligible due to plug flow and a homogenous cell 
distribution in radial direction  
• radial porosity profile is neglected 
• convective and dispersive mass transport 
• constant dispersion coefficient over the fixed bed region  
• the growth rate depends on the glucose concentration (Monod-kinetic) and is 
independent from the oxygen concentration  
• no cell lysis or apoptosis 
• Monod kinetic for glucose and zero order kinetic for oxygen consumption  
• isothermal conditions (37°C) 
• laminar flow ( Re  < 10) 
Since glutamine was reported as an unimportant energy source for hMSC only the 
oxygen and glucose kinetics were taken into account [7].  
Figure 1 gives an overview of the model, which considers the mass balance of 
the conditioning vessel and the fixed bed.   
The temporally and spatial concentration profile ic  of nutrient i  in the fixed bed 
can be described by a steady state convection-dispersion-reaction equation:  
 
2
2
i i i
ax i FB
c c cv D q X
t z z
δ δ δ
ε
δ δ δ
⋅ = − ⋅ + ⋅ − ⋅   Equation 1 
 
with the Danckwerts boundary condition for the inlet and outlet boundary:   
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axD  is the axial dispersion coefficient, ε  the porosity, iq  the consumption rate, v  the 
superficial velocity, V  the volume flow, and FBX  the volume specific cell density. Cell 
growth during the exponential phase can be expressed as a first order kinetic:  
 
FB
FB
dX X µ
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= ⋅
     Equation 4 
 
The growth rate µ  depends on the glucose concentration Glc r Rc =  at the carrier 
surface according to a Monod kinetic: 
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,
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=
=
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+
    Equation 5  
  
The glucose consumption rate Glcq  is also a function of the glucose concentration 
Glc r R
c
=
:  
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, Glc
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c
q q
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=
=
= ⋅
+
   Equation 6 
 
whereas the oxygen uptake rate Oxq  is regarded as independent from the 
concentration and thus constant: 
 
.Oxq const=       Equation 7 
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For calculation of the concentration i r Rc =  at the carrier surface a diffusive mass 
transfer through the hydrodynamic boundary layer is assumed, which is in equilibrium 
with the nutrient consumption of the cells at the carrier surface (Figure 2):  
 
, ( )i l i i i A ir R
N k c c X q
A =
= ⋅ − = ⋅

   Equation 8 
 
The mass transfer coefficient ,l ik  can be calculated by a Sherwood relation [8]: 
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   Equation 9 
 
with the Schmidt and  Reynolds number: 
 
,i M
Sc
D
η
ρ
=
⋅      Equation 10 
 
v dRe = ρ
η
⋅ ⋅
     Equation 11 
 
,i MD  is the molecular diffusion coefficient of the nutrient i  and η  and ρ  are the 
viscosity and density of the medium, respectively.  
The time dependent change in glucose content in the conditioning vessel is 
composed of the flux ,i FBV c⋅  from the fixed bed to the conditioning vessel and the 
flux ,i CVV c⋅  out of the conditioning vessel to the fixed bed (Figure 1): 
 
,
, ,
Glc CV
CV Glc FB Glc CV
dc
V V c V c
dt
⋅ = ⋅ − ⋅ 
  Equation 12 
 
In the case of oxygen an additional term, the oxygen transfer rate OTR , arises:    
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,
, ,
Ox CV
CV Ox FB Ox CV
dc
V V c V c OTR
dt
⋅ = ⋅ − ⋅ + 
 Equation 13 
 
The oxygen transfer rate can be calculated with the volumetric oxygen transfer 
coefficient lk a  and the maximal oxygen saturation 
*
Ox
c : 
 
*
,( )l CV Ox Ox CVOTR k a V c c= ⋅ ⋅ −    Equation 14 
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Methods 
The cultivations in scales of up to 300 cm3 were performed as previously described in 
part A of this publication (Table 1) [3]. Following model parameters were fitted to the 
experimental data: 
• initial cell density 0FBX  (differs from inoculated cell density)  
• maximal glucose uptake rate ,maxGlcq  
• Monod constant for glucose uptake kinetic , GlcM qK  
• oxygen uptake rate Oxq  
• maximal growth rate maxµ  
• Monod constant for growth kinetic , GlcM µK  
• volumetric oxygen transfer rate lk a  
The superficial velocity was restricted to 3 x 10-4 m s-1 by using of the mean growth 
rate as indicator (see part A) [3]. Since the maximal superficial velocity is restricted, 
the fixed bed height FBh  depends mainly on the target cell density 
n
FBX  and the 
minimal tolerable oxygen saturation of the medium. The lowest oxygen saturation 
,Ox FBs  can be found in the outlet region. The inflow was presumed to be saturated 
with normal air (approx. 20% oxygen) that means a concentration of dissolved 
oxygen of 6.88 µg mL-1. The defined fixed bed height FBh  allowed a calculation of the 
thickness-ratio TR  dependent maximal fixed-bed volume and thus the scaling of a 
single fixed-bed: 
 
2
2
FB
FB FB
hV h
TR
π  = ⋅ ⋅ ⋅     Equation 15 
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A further up-scaling of the reactor system can only be performed by increasing the 
number of parallel operated fixed-beds FBn . The number FBn  needed for the target 
cell number nXN  can be calculated as follows: 
 
n
X
FB n
FB FB
Nn
X V
=
⋅     Equation 16 
 
Simulations of the up-scaled cultivation process were performed with selected 
parameter settings (Table 7).  
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Results and Discussion 
 
The cell line hMSC-TERT was cultured in scales of 14, 60, and 300 cm3. Figure 3 to 
Figure 5 show the experimental data as well as the according simulated curves. The 
results are summarized in Table 5.   
Most model parameters of the cultivation in the 14.2- and 60-cm3 fixed-bed 
reactors (passage number 68 and 71) are comparable to those obtained in 6-well cell 
culture plates (passage number 69) or at least within the two sigma range. The 
plausibility of the fitted parameters and thus of the model by itself can be confirmed 
by the mean growth and consumption kinetics obtained with the simplified 
calculations without consideration of concentration dependencies and mass transfer 
resistances (Table 2 and part A) [3]. All kinetics are in the range of those reported for 
several animal and human cells or cell lines (see part A and Table 4).  
The cells were cultured up to a density nFBX  of (2.93 ± 0.11) x 106 cells/cm3. 
Higher cell densities are not recommendable because of the risk of channeling and 
drawbacks by up-scaling of the fixed bed system as shown below. The initial cell 
densities 0FBX  (
0
AX )  were about 50% of the inoculated cell densities that confirms 
the results of the inoculation procedure in part A [3].  
 The maximal growth rate maxµ  and the oxygen consumption rate Oxq  decreased 
with advancing passage number from 0.69 to 0.55 d-1 and 2.14 x 10-8 to about 
1.1 x 10-8 mg h-1 cell-1. The maximal glucose consumption rate ,maxGlcq  increased  
from 8.0 x 10-8 to 11.8 x 10-8 mg h-1 cell-1. As a consequence of these changes in 
growth and consumption kinetics process optimizations and scale up calculations are 
only valid for a closed range of passage numbers.  
When a fixed superficial velocity v  and an  oxygen saturation ,Ox CVs  of 100% at 
the inlet 
 
is assumed, the maximal fixed bed height FBh  is a function mainly of the cell 
density FBX  and the minimal oxygen saturation in the fixed bed ,Ox FBs , which can be 
found as already mentioned at the outlet region. Thus the feasible fixed bed height 
decreases with increasing outlet oxygen saturation and cell density. By using 
Equation 15 and Equation 16 one obtains the numbers and volumes of parallel 
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operated fixed-bed reactors needed for the exemplified cultivation of twenty billion 
cells as a function of the thickness ratio TR , outlet oxygen saturation ,Ox FBs , and cell 
density at the end of cultivation nFBX  (Table 6). For example, a thickness ratio of 
three, an outlet oxygen saturation of 40% as well as a cell density of 3.66 x 106 
cells/cm3 means a maximal volume of a single bed of 17 cm3 and because of this 
small fixed bed volume a number of 312 parallel operated reactors. This is very 
unpractical in handling and operating. Thus, it is recommended to reduce the 
thickness ratio, cell density, and to an uncritical value, the outlet oxygen saturation. 
Indeed this leads to an increase of the total fixed bed volume but reduces the number 
of needed reactors due to a greater volume of a single fixed bed. For instance a cell 
density of 9.15 x 105 cells/cm3, a thickness ratio of one, and an oxygen saturation at 
the outlet of 20% result in a single reactor of about 22 Liters. This is a considerable 
decrease in complexity of the reactor system for the cultivation of twenty billion 
hMSC-TERT.  
The dissolved oxygen saturation at the carrier surface Ox r Rs =  differs slightly from 
those of the bulk medium due to the mass transfer resistance of the hydrodynamic 
boundary layer (Figure 2). This difference increases with increasing cell density.  
A positive effect of hypoxic conditions on the proliferation rate and maintenance 
of the undifferentiated state was described in several publications [9-13]. Additionally 
it could be shown that mesenchymal stem cells, which had been cultured under 
hypoxic conditions (2 - 5% oxygen in the aeration gas) showed a better differentiation 
potential when transferred to  normoxic conditions [10, 11]. It could be gathered from 
this that an oxygen saturation of 20% is sufficient or even supportive for the 
expansion cultivation and could be, when indicated, more reduced. However, this 
demands further investigations.  
Figure 8 shows the glucose concentration in the medium Glcc  versus the cell 
density FBX  for maintaining some presetted growth rates µ , which depend on the 
glucose concentration at the carrier surface Glc r Rc = . The effect of the cell density is 
insignificant at least in the presented range of up to 4.6 x 106 cells/cm3 and a minimal 
glucose saturation in the medium of 0.135 mg mL-1. This speaks for a negligible 
mass transfer resistance for glucose despite of a smaller mass transfer coefficient 
compared to those of oxygen. This can be explained by the fact that the glucose 
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concentration and thus the driving force for the mass transfer is of magnitudes 
greater.  
Four simulations at a twenty-billion-cells scale with several combinations of initial 
and target cell densities as well as minimal oxygen saturation at the outlet and 
medium volume in the conditioning vessel were performed exemplarily (Table 7). The 
results of these simulations are shown in Table 8. The simulations 1 and 4 are shown 
graphically in Figure 9 and Figure 10.   
The longest cultivation time of 233 h shows simulation 4. This is mainly due to 
the small initial density 0FBX  of 1.83 x 10
4 cell/cm3 (1000 cells/cm2). This low initial cell 
density and the target cell density nFBX  of 1.83 x 10
6 cell/cm3 means an amplification 
of the initial cell number of the factor 100. The amplification factor of the simulations 1 
to 3 is only 20. Considering the yield of adherent cells after the inoculation procedure 
of about 50% and the yield as well as vitality after the harvesting procedure of 82% 
and 96%, respectively, the efficiency of the cultivation is additionally lowered. The 
amplification factor of the simulation 1 to 3 is then 7.9 and those of the simulation 4 of 
about 40. For enhancing of the overall yield of the cultivation process, the initial cell 
density can be reduced or the target cell density can be increased. The latter would 
lead, as already discussed, to a higher number of parallel operated fixed beds and 
thus to an increased complexity of the system. A small initial cell density can 
enhance the growth rate but stretches the lag-phase [14, 15]. Moreover the cells 
would growth in clusters which has some drawbacks concerning the harvest 
procedure and nutrient supply. A compromise has to be found between the two 
possibilities reduction of the initial cell density or enhancement of the target cell 
density. Furthermore the inoculation procedure has to be optimized in order to reduce 
the needed inoculum.  
Since the growth rate depends on the glucose concentration the cultivation time 
of up to 233 h can be reduced by increasing of the medium volume and thus the 
glucose mass. But this would mean a suboptimal exploitation of the medium. The 
medium should be added step wise to the process and stored at 4°C in order to avoid 
a degradation of thermolabile components.   
The greatest difference between the glucose concentration Glcc  at the inlet and 
outlet is 0.022 mg/mL or 7.5%, respectively (simulation 1). This has to be considered 
by measuring the glucose concentration for process monitoring in the conditioning 
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vessel. Due to the low solubility of oxygen the decrease in axial direction is with 70% 
to 80% much greater, which means a permanent aeration of the medium in the 
conditioning vessel in order to obtain an oxygen-saturated inflow of the fixed bed. 
The relative difference between the glucose concentration in the medium Glcc  and at 
the carrier surface Glc r Rc =  at the end of the cultivation is smaller than  0.8% and can 
be neglected  just as the oxygen difference between the medium and carrier surface, 
which is of about 1 - 2%, dependent on the cell density.  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Conclusion 
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A fixed-bed bioreactor system based on non-porous borosilicate glass carrier for the 
expansion of hMSC-TERT or hMSC and a scale-up procedure is introduced in this 
experimental and modeling study. The scalable fixed bed enables the expansion and 
harvesting of hMSC with high yield and vitality and offers an easy automation of the 
entire process including the inoculation, cultivation, and harvesting procedure (see 
part A of this publication) [3].  
Scale-up calculations based on the experimentally determined oxygen 
consumption of the cells have revealed that reaching as much as possible high target 
cell densities is counterproductive in scaling of the process. Assuming a limited 
superficial velocity, the volume of a single fixed bed drastically decreases with 
increasing cell density, oxygen outlet concentration, and thickness ratio. This means 
a great number of parallel operated fixed beds and thus an enhanced complexity of 
the system. Therefore, it is recommendable to decrease the cell density as well as 
the thickness ratio and, certainly only to an uncritical value, the minimal oxygen 
saturation at the outlet. This leads to a reduction of the fixed bed number and thus 
simplifies the up-scaled system.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix 
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Determination of the axial dispersion coefficient 
For experimental determination of the axial dispersion coefficient in equation 
Equation 1 and Equation 2 a step function using ethylene violet stained water was 
applied at the inlet of the fixed-bed reactor, which then displaced the unstained 
water. Samples were taken at the outlet and the extinction as a measure for the 
concentration was determined photometrically. The normalized concentrations C  
were plotted against the normalized times /tθ = Τ , where Τ  is the mean residence 
time in the fixed-bed reactor. The Bodenstein number  
 
FB
ax
v hBo
D
⋅
=
         
Equation 17 
 
which contains the axial dispersion coefficient axD  was then calculated by fitting the 
dimensionless convection-dispersion equation 
 
2
2
1C C C
Z Bo Z
δ δ δ
δθ δ δ
= − + ⋅
       
Equation 18 
 
to the experimental data. The boundary conditions were given by: 
 
0 0
0
1
Z Z
Z
CC C
Bo Z
δ
δ
− +
+
= =
=
= − ⋅
      
Equation 19 
 
1
0
Z
C
Z
δ
δ =
=
         
Equation 20 
 
An overview of examined fixed bed dimensions and superficial velocities is given in 
table Table 9. 
 
Nomenclature 
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A   Growth surface [m2] 
Bo   Bodenstein number [-] 
C   dimensionless concentration [-] 
0
Glcc   initial glucose concentration [kg m-3] 
Glcc   glucose concentration in the fixed bed [kg m-3] 
,Glc CVc   glucose concentration in the conditioning vessel (fixed-bed inlet) [kg m
3] 
,Glc FBc   glucose concentration in the fixed-bed outlet [kg m3] 
ic   concentration of nutrient i  [kg m-3] 
,i FBc   concentration of nutrient i  in the fixed-bed outlet [kg m-3] 
,i CVc   concentration of nutrient i  in the conditioning vessel [kg m-3] 
*
Oxc   maximal dissolved oxygen [kg m-3] 
,Ox CVc   oxygen concentration in the conditioning vessel (fixed-bed inlet) [kg m3] 
,Ox FBc   oxygen concentration in the fixed-bed outlet [kg m3] 
d   sphere diameter [m] 
axD   axial dispersion coefficient [m2 s-1] 
,i MD   molecular diffusion coefficient of nutrient i  [m2 s-1] 
 FBh   fixed bed height [m] 
hMSC  human mesenchymal stem cells 
lk a   volumetric oxygen transfer coefficient [s-1] 
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,l ik   mass transfer coefficient [m s-1] 
,M µK   Monod constant for growth kinetic [kg m-3] 
, GlcM q
K  Monod constant for glucose consumption [kg m-3] 
FBn   number of parallel operated fixed beds [-] 
N   mass flow rate [kg s-1] 
n
XN   cell number at the end of cultivation [-] 
OTR   oxygen transfer rate [kg m-3 s-1] 
Glcq   glucose consumption rate [kg s-1 cell-1]  
,maxGlcq  maximal glucose consumption rate [kg s
-1 cell-1] 
iq   consumption rate of nutrient i  [kg s-1 cell-1] 
Oxq   oxygen consumption rate [kg s-1 cell-1]  
Re    Reynolds number  [-] 
Sc   Schmidt number [-] 
Sh   Sherwood number [-] 
,Ox FBs   oxygen saturation in the fixed-bed outlet [%]  
,Ox CVs   oxygen saturation in the conditioning vessel (fixed-bed inlet) [%] 
TR   thickness ratio [-] 
v   superficial velocity [m s-1] 
V   volume [m3] 
V   flow rate [m3 s-1] 
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FBV   fixed bed volume [m3] 
CVV   medium volume (conditioning vessel) [m3] 
AX   area related cell density [m-2] 
FBX   volume related cell density [m3] 
0
FBX   initial volume related cell density [m3] 
n
FBX   volume related cell density at the end of cultivation [m-3]  
Z   dimensionless z-coordinate [-] 
jt∆   time intervall 1j jt t −−    j  = 1, 2, 3 … n  
ε   void volume of the fixed bed (porosity) [-] 
η   dynamic viscosity [Pa s ] 
µ   growth rate [s-1] 
maxµ   maximal growth rate [s-1] 
ρ   density of the medium [kg m3] 
θ   dimensionless time [-] 
Τ   mean residence time [s] 
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Figures 
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Figure 3 
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  XFB, calculated from oxygen consumption  
  XFB, counting of nuclei at the end of cultivation  
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Figure 4 
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  XFB, calculated from oxygen consumption  
  XFB, counting of nuclei at the end of cultivation  
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Legends 
Figure 1: Illustration of the mass balances of the fixed bed and the associated 
conditioning vessel. 
 
Figure 2: Overview to the mass transport phenomena at the carrier surface. 
 
Figure 3: Experimental and simulated data of a hMSC-TERT cultivation in four 
parallel operated 14.2-cm3 fixed-bed reactors. For calculation of the cell density from 
the oxygen consumption it was supposed that the cells in the reactor were 100% vital 
since non-vital cells get flushed out by the medium flow.  
v  = 2.7 x 10-4 m s-1; CVV = 1000 ml 
 
Figure 4: Experimental and simulated data of a hMSC-TERT cultivation in a 60-cm3 
fixed-bed reactor.  
v  = 3.0 x 10-4 m s-1; CVV = 500 ml 
 
Figure 5: Experimental and simulated data of a hMSC-TERT cultivation in a 300-cm3 
fixed-bed reactor.  
CVV = 4800 ml 
 
Figure 6: Simulated maximal fixed bed height FBh  as a function of the cell density 
FBX  and the oxygen saturation at the outlet. A fixed superficial velocity v  of 
3.0 x 10-4 m s-1 and oxygen saturation at the inlet of 100%, related to normal air with 
21% oxygen, was assumed.  
 
Figure 7: Oxygen saturation at the carrier surface versus oxygen saturation in the 
medium for different cell densities.   
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Oxq  = 2.1 x 10
-8 m s-1; v  = 3.0 x 10
-3 m s-1 
Figure 8: Dependence of the glucose concentration Glcc  in the medium, which is 
necessary for maintaining certain growth rates µ , on the cell density FBX . The given 
growth rates arises from Equation 6 by replacing the glucose concentration at the 
carrier surface Glc r Rc =  by multiples of the Monod constant ,M µK .  
maxµ  = 0.55 d
-1; ,M µK  = 0.135 mg ml
-1; ,maxGlcq  = 1.2 x 10
-7 mg h-1 cell-1, , GlcM qK  = 1.0 
mg ml-1; v  = 3.0 x 10
-3 m s-1 
 
Figure 9: Simulation 1 – hMSC-TERT cultivation in production scale on 2-mm 
borosilicate glass spheres in a fixed-bed reactor. 
FBn  = 4; FBV  = 2,905 cm
3; TR  = 1.0; CVV  = 150 l; 
0
FBX  = 9.15 x 10
4 cells/cm3 
(5.0 x 103 cells/cm2); nFBX  = 1.83 x 10
6 cells/cm3 (1.0 x 105 cells/cm2); minimal 
oxygen saturation at the outlet ,Ox FBs  = 20%; v  = 3.0 x 10
-4 m s-1 
 
Figure 10: Simulation 4 – hMSC-TERT cultivation in production scale on 2-mm 
borosilicate glass spheres in a fixed-bed reactor. 
FBn  = 6; FBV  = 1,946 cm
3; TR  = 1.0; CVV  = 200 l; 
0
FBX  = 1.83 x 10
4 cells/cm3 
(1.0 x 103 cells/cm2); nFBX  = 1.83 x 10
6 cells/cm3 (1.0 x 105 cells/cm2); minimal 
oxygen saturation at the outlet ,Ox FBs  = 30%; v  = 3.0 x 10
-4 m s-1 
 
Figure 11: Simulated and experimental step response of fixed-bed reactors consisted 
of 2-mm non-porous glass spheres. 
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Tables 
 
Table 1: Performed hMSC-TERT cultivations in fixed bed bioreactors at different 
scales.  
Fixed bed 
volume FBV  
[cm3] 
Growth 
surface FBA  
[cm2] 
Inoculated 
cell density   
[cm-2] 
Medium 
volume CVV  
[mL] 
Superficial 
velocity v  
[m s-1] 
Medium 
changes  
[h] 
Cultivation 
time  
[h] 
4 x 14.2 4 x 260 10,000 1,000 2.65 x 10-4 115 135 
60 1098 7,000 500 3.0 x 10-4 - 168 
300 5490 10,000 4,800 (0.8– 3.3) x 10-4  149 167 
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Table 2: Results of the hMSC-TERT cultivation in 2-mm borosilicate glass spheres comprising fixed-bed reactors – simplified 
calculations (see part A of this publication) [3].  
 Parameter Units FBV  = 4 x 14.2 cm
3 FBV  = 60 cm
3 FBV  = 300 cm
3 
Passage number - 68 71 84 
Mean growth  rate mµ  [d-1] 0.60 ± 0.02 0.49 ± 0.04 0.42 ± 0.02 
Mean glucose consumption rate ,mGlcq  [mg h-1 cell-1] (7.65 ±  0.3) x 10-8 (6.80 ± 0.43) x 10-8 (9.50 ± 0.27) x 10-8 
Oxygen consumption rate Oxq  [mg h-1 cell-1] 2.03 x 10-8 2.06 x 10-8 1.08 x 10-8 
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Table 3: Parameters and coefficients used for modeling of the fixed bed cultivation. Kinetic parameters are given in Table 5.  
Parameter Units Value Reference Remarks 
 Initial glucose concentration [mg L-1] 1000 Biochrom EMEM 
 Maximal oxygen saturation  [mg L-1] 6,88 [16] 37°C, atmospheric pressure, 21% O2 
 Diffusion coefficient for glucose [cm2 s-1] 7.0 x 10-6 [17] in water, 30°C 
 Diffusion coefficient for oxygen 
[cm2 s-1] 3.24 x 10-5 [18] in water, 40°C 
[cm2 s-1] 1.97 x 10-5 [18] in water, 30°C 
[cm2 s-1] 2.86 x 10-5 interpolated 37°C 
 Porosity [-] 0.39 experimental 
randomly packed bed of monodisperse 
spheres 
 Dynamic viscosity of medium 
[Pa s] 7.4 x 10-4 [19] DMEM + 5 % FCS , 37°C 
[Pa s] 7.8 x 10-4 [19] DMEM + 25 % FCS , 37°C 
[Pa s] 7.5 x 10-4 interpolated DMEM + 10 % FCS , 37°C 
 Density of medium  [kg m-3] 1003 [19] DMEM, 37°C 
Bo  Bodenstein number [-] 8.1 experimental see appendix 
0
Glcc
*
Oxc
MD
MD
ε
η
ρ
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Table 4: Range of growth and consumption rates of animal cells. 
Parameter Value Reference 
Growth rate µ  [d-1] 0.23 – 1.56 [7, 20-25] 
Glucose consumption rate Glcq  [mg h-1 cell-1] (0.9 – 1.6) x 10
-7 [7, 26-32] 
Oxygen consumption rate Oxq  [mg h-1 cell-1] (1.1 – 3.2) x 10
-8  [33-37] 
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Table 5: Growth and consumption kinetics of hMSC-TERT during the cultivations in 2-mm borosilicate glass spheres comprising 
fixed-bed reactors and 6-well cell culture plates. Bold-faced values were determined by fitting of the model parameters to the 
experimental data. Underlined kinetic parameter were used for scale up considerations.  
 Reference Units FBV  = 4 x 14.2 cm
3 FBV  = 60 cm
3 FBV  = 300 cm
3 6-Well [3] 
Cultivation time [h] 135 168 167,3 173,5 
End cell density nFBX  
[cm-2]  
[cm-3] 
(1.60 ± 0.06) x 105  
(2.93 ± 0.11) x 106  
9.56 x 104  
1.75 x 106  
1.12 x 105  
 2.05 x 106 
6.5 x 104 *  
Passage number - 68 71 84 68 
Superficial velocity v  [m s-1] 2.7 x 10-4 3.0 x 10-4 (0.8 – 3.3) x 10-4 0 
Axial dispersion coefficient axD  
( Bo  = 8.1) 
[m2 s-1] 1.47 x 10-6 3.89 x 10-6 3.18 x 10-6 - 
Initial cell density 0AX   and 
0
FBX  
[cm-2]             
[cm-3] 
5.50 x 103      
9.15 x 104 
3.50 x 103       
6.40 x 104 
5.00 x 103             
9.12 x 104 
5.00 x 103             
 
Maximal growth  rate maxµ  [d-1] 0.69 0.58 0.66 ± 0.02 0.55 
Monod constant ,M µK  [mg mL-1] 0.14 0.16 0.14 ± 0.03 0.14 
Maximal glucose consumption  
rate ,maxGlcq  
[mg h-1 cell-1] 8.0 x 10-8 9.15 x 10-8 (7.65 ± 1.11) x 10-8 1.18 x 10-7 
Monod constant , GlcM qK  [mg mL
-1] 0.15 0.16 0.16 ± 0.06 0.10 
Oxygen consumption rate Oxq  [mg h-1 cell-1] 2.05 x 10-8 2.14 x 10-8 
0.98 x 10-8 (0 - 100 h)    
1.11 x 10-8 (100 - 146 h)  
1.62 x 10-8 (146 - 167 h) 
- 
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lk a  [h-1] 2.15 1.6 2.22 - 
* Glucose limitation 
** Appendix     
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Table 6: Numbers and volumes of parallel operated fixed beds needed for the cultivation of twenty billion cells.  
 Thickness ratio = 1 Thickness ratio = 2 Thickness ratio = 3  
Target cell density  
n
FBX  
( )nAX  
[cm-3] ([cm-2]) 
Fixed bed 
volume FBV  
[cm3] 
Number of  
fixed beds FBn  
Fixed bed 
volume FBV  
[cm3] 
Number of  
fixed beds FBn  
Fixed bed 
volume FBV  
[cm3] 
Number of  
fixed beds FBn  
Total fixed bed 
volume for 
2 x 1010 cells 
[cm3] 
Outlet oxygen saturation ,Ox FBs  =  20%                     
9.15 x 105  (5.0 x 104) 23,241 0.9 5,810 3.8 2,582 8.5 21,858 
1.83 x 106  (1.0 x 105) 2,905 3.8 726 15.1 323 33.9 10,929 
2.75  x 106  (1.5 x 105) 861 8.5 215 33.9 96 76.2 7,286 
3.66  x 106  (2.0 x 105) 363 15.1 91 60.2 40 135.4 5,464 
Outlet oxygen saturation ,Ox FBs  = 30%  
9.15 x 105  (5.0 x 104) 15,570 1.4 3.892 5.6 1730 12.6 21,858 
1.83 x 106  (1.0 x 105) 1,946 5.6 487 22.5 216 50.5 10,929 
2.75  x 106  (1.5 x 105) 577 12.6 144 50.5 64 113.7 7,286 
3.66  x 106  (2.0 x 105) 243 22.5 61 89.9 27 202.2 5,464 
Outlet oxygen saturation ,Ox FBs  = 40%  
9.15 x 105  (5.0 x 104) 9,805 2.2 2.451 8.9 1.089 20.1 21,858 
1.83 x 106  (1.0 x 105) 1,226 8.9 306 35.7 136 80.3 10,929 
2.75  x 106  (1.5 x 105) 363 20.1 91 80.3 40 180.6 7,286 
3.66  x 106  (2.0 x 105) 153 35.7 38 142.7 17 321.0 5,464 
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Table 7: Performed simulations of the hMSC-TERT expansion process based on 
fixed-bed reactors with 2-mm borosilicate glass spheres. Target cell number =  
2.0 x 1010 cells 
Simulation 1 2 3 4 
Initial cell density 0FBX  [cm-3] 9.15 x 10
4 9.15 x 104 4.58 x 104 1.83 x 104 
Target cell density nFBX  [cm-3] 1.83 x 106 1.83 x 106 9.15 x 105 1.83 x 106 
Outlet oxygen saturation ,Ox FBs  by 
achieving the target cell density  [%] 
20 30 20 30 
Fixed bed height FBh  [cm] 15.47 13.53 30.95 13.53 
Fixed bed volume of a single  
reactor FBV   [cm3] 
2,905 1,946 23,241 1,946 
Number of fixed-bed reactors FBn  [-] 
(calculated) 
4 (3.76) 6 (5.6) 1 (0.94) 6 (5.6) 
Total fixed bed volume [cm3] 11,620 11,676 23,241 11,676 
Total fixed bed volume needed for the 
cultivation of  2 x 1010 cells  [cm3] 
10,929 10,929 21,858 10,929 
Medium volume CVV  [L] 150 125 150 200 
Axial dispersion coefficient axD  [m2 s-1] 5.73 x 10-6 5.01 x 10-6 1.14 x 10-5 5.01 x 10-6 
Superficial velocity v   [m s-1] 3.0 x 10-4 
Oxygen saturation at the inlet ,Ox CVs  
[%] 
100 
Thickness ratio TR  [-] 1.0 
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Table 8: Results of the simulations of hMSC-TERT cultivations in fixed-bed reactors 
consisting of 2-mm borosilicate glass spheres. The data are related to the point of 
reaching the target cell density nFBX .  
Simulation 1 2 3 4 
Time until reaching the target 
cell density [h] 
155.0 158.8 154.6 232.8 
Total cell number [-] 2.13 x 1010 2.14 x 1010 2.13 x 1010 2.14 x 1010 
Glucose concentration in the 
conditioning vessel  ,Glc CVc  
[mg mL-1] 
0.292 0.143 0.314 0.438 
Glucose concentration at the 
outlet ,Glc FBc  [mg mL-1] 
0.270 0.128 0.292 0.422 
Glucose concentration at the 
carrier surface Glc r Rc =  (upper 
fixed bed area) [mg ml-1] 
0.269 0.127 0.291 0.421 
Oxygen saturation at the outlet 
,Ox FBs   [%] 
20.0 30.0 20.0 30.0 
Oxygen saturation at the carrier 
surface Ox r Rs =   (upper fixed 
bed area) [%] 
17.8 27.8 18.9 27.8 
Growth rate µ   [d-1] 0.37 0.27 0.38 0.42 
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Table 9: Overview of the fixed bed dimensions and superficial velocities used for 
determination of the axial dispersion coefficient. 
Fixed bed volume 
FBV   [cm3] 
Sphere diameter 
 d  [mm] 
Fixed bed 
height FBh    
[cm] 
Fixed bed 
diameter FBd   
[cm] 
Superficial velocity 
 v  [m s
-1] 
50 2.0 8.7 2.7 2.91 x 10-4 
100 2.0 11.9 3.4 1.84 x 10-4 
127 2.0 14.0 3.4 3.32 x 10-4 
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